Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Possible. We are currently valued at £18m based on today's price. Ebers could probably buy us out for <£30 odd million, sell NXP2 to recoup the money and get the CBD stuff for free.
I completely agree that shareholder communication has been awful. No wonder people keep mistaking NFX for an AIM listed company. I have been a holder for over a year now and have never received a reply back to an email or message. I have held (and continue to do so) due to the potential.
The big question for me is why would anyone leave (especially if a company founder) if you are on the cusp of a potential major deal that you have been working on for ages?
The only positive spin I can put on this is that in some way the potential partners (or indeed Ebers now that DT is there) were not happy with Dan and as a condition of moving forward wanted to deal with someone else.
The alternative is that Dan was stringing everyone along all this time, which I don't even want to think about.
It doesn't look like DT is selling (at the moment) and if the same goes for Dan then I think that bodes well for the future.
If anyone at NFX is reading this board - you guys really need to improve your comms to us little shareholders! You can start with a Q&A webinar once your new CEO is announced.
Just seen ODX fundraising at at 27% discount to their 30 day price. Makes ours at a 4.4% discount look fantastic. I know a lot of us pretty miffed at the placing especially when told we were funded until 2021 but I think we will look back on it as an absolutely great business decision. I think with AS as CEO we have something very rare - not only a brilliant scientist but also someone who understands how to drive the business forward.
Interesting that the Sona CEO (who looks very young!) mentions how the companies they are collaborating which I found surprising. Also he reiterates need for 100s of millions of tests. Finally not only is the challenge to come up with a good test (something like 95% sensitivity) but the actual manufacturing and supply chain issues.
Personally I am taking great confidence in there being 2 presentations on Thursday (1 for IIs and 1 for retail. The strategic investor and others will not be ploughing 10s of millions in the placing for a quick few pence flip of the shares. Therefore AS must definitely have something decent to report in the next few days otherwise everything else it out in the open via RNSs and on the company website with the updated pdfs of presentations.
" We are very pleased to have added a significant strategic US investor to our register"
Yes that line stood out for me as well. Can definitely see a move to the Nasdaq now. What start out this morning at 7:00am with alot of anger is now slowly turning into acceptance that today was the Avacta moved into the big league.
Yes agreed - it does feel like people seem a lot more blasé about covid - even locally when shopping not many people wearing masks etc. But I do think businesses will be taking it more seriously especially the travel industry in order to give confidence to people to travel so quick tests will be in demand for a good while I think.
Alastair Smith really interviews well. He's a scientist who seems to have a grasp of the marketing opportunity in front of him and is pursuing every avenue available. The Medusa19 partnership is not just for Covid but future consumer testing as well in areas I presume such as allergy testing. The comment at the end was interesting - they need a "large pharmaceutical company" to pursue rapid clinical programme.
Just seen REDX Pharma rise nearly 300% from yesterday - private takeout offer of 15p from yesterdays price of around 5p. Specialise in cancer & fibrosis. Hmmm who do we know that does that as well?
Shortage of stock - taste of what could happen on some good news.
No worries - hope you get better quickly - you haven't been to China recently to demand our payment have you?
Chablard - not sure what you are on about - he has 3m warrants @6.75 - but he still has to pay for them they aren't just given to him.
I think they have to notify on every %point increase or decrease in shareholding. On the RNS of 27th Jan they were down to 9.8% . Looking at the large trades since then, if it is I think CPI selling then I am expecting another holding RNS back end of next week (taking the delay in reporting the notification by NFX)
Would be great if they can dump everything on the 1st decent RNS we get, that way we are more likely to hold onto the gains on any subsequent (good) RNS.
Think I would have been happier if Dan had said nothing further about the NXP1 payment - putting a hard date as "by CNY" wasn't really needed and it only adds to uncertainty. The share price action this week is telling me people are not expecting a payment now so I guess it's going to continue it's drift down, certainly tomorrow and Friday... then slowly start going up as people get the "FOMO" feeling as good news has to come sometime.
Still think that a few months down the line these little sub penny movements will be a thing of the past and hopingto be well into double digits if the things Dan mentioned in his last interview come to fruition.
Jilson - "I’m out! Sold up yesterday at same price I bought on Friday." bloody hell is that the new definition of a LTH?